Practical Details

Organisers: European Brain Council & Danish Brain Council
Date: 8 December 2025, 16:00 – 17:30 CET
Location: Virtual Webinar

Schizophrenia remains a major public health challenge, with significant personal, social and economic consequences. Traditional approaches to schizophrenia focus primarily on mental health interventions, yet emerging evidence underscores the need for a brain health perspective—one that acknowledges the interplay between biological, psychological and social determinants.

The webinar A Comprehensive, High-Quality Approach to the Treatment of Schizophrenia in Adolescents and Young Adults, building on the second and third phase of the Rethinking Schizophrenia Project, will explore how early intervention, innovative treatments and social policy reforms can reshape schizophrenia care across Europe. The webinar, set to take place online on 8 December 2025 (16:00-17:30 CET), will discuss and present country-specific findings, illustrating barriers and best practices in implementing comprehensive care pathways in Denmark. Experts will discuss youth-focused key policy recommendations, including early detection programs, access to innovative pharmacological and psychosocial treatments, integrated care models and digital health solutions. The webinar will highlight the importance of addressing the Quality Care for Child and Adolescent Health with a Focus on Brain Health – The Case of Schizophrenia.

Participants will include leading psychiatrists and other key mental health professionals, policymakers in the field of public health and social affairs, education and patient representatives, fostering a multidisciplinary dialogue on bridging research, clinical practice and policy. The discussion will focus on implementing a brain health framework that prioritises prevention, personalised care and long-term rehabilitation. By adopting a biopsychosocial approach and integrating brain health into national policies, we can shift the paradigm in schizophrenia care—ensuring earlier interventions, better treatment outcomes and enhanced quality of life for young patients across Europe.